home

Home> Latest Approval >New Combination >Main Body

Latest Approval

U.S. Food and Drug Administration Approves Gilead’s Second TAF-Based Single Tablet Regimen Odefsey® (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) for the Treatment of HIV-1 Infection

2016-03-03 14:33

New Combination

Source：Gilead Sciences

Read：296 Favorite 0

Share

相关阅读

You may interest

Copyright©2020 药渡经纬信息科技（北京）有限公司电子与信息服务业务经营许可证151001号

京ICP备14047345| 京公安网备11010802017043号 |（京）-经营性-2015-0023（互联网药品信息服务资格证书）

: 药渡APP

: 微信二维码